16.4 C
London
HomeBusiness News

Business News

Abivax trading halt on Euronext Paris in context of U.S. ADS offering

Abivax trading halt has been imposed on Euronext Paris from 9:00 a.m. CEST on 24 July 2025. This temporary suspension was initiated by the company to allow final confirmation of investor allocations and disclosure of pricing related to its public offering of American Depositary...

Corpay to Acquire Alpha Group: Expanding Cross-Border FX for Institutional Growth

Corpay to Acquire Alpha Group in a strategic move aimed at consolidating its presence in the B2B cross-border foreign exchange sector. This acquisition marks a significant milestone for Corpay as it accelerates its entry into the investment fund segment—a client base that aligns with...

Faraday Future Partners with HabitTrade to Enter Web3 Financial Ecosystem

Faraday Future Partners with HabitTrade marks a strategic entry into the Web3 financial ecosystem for Faraday Future. This collaboration establishes a robust foundation for the company’s expansion beyond electric mobility into digital finance. Strategic Collaboration Faraday Future has formed a strategic alliance with HabitTrade, a global...

Wolters Kluwer to divest Finance, Risk and Regulatory Reporting unit

Wolters Kluwer to divest Finance, Risk and Regulatory Reporting unit to Regnology Group GmbH for €450 million, under a binding agreement announced July 21, 2025. This strategic transaction will enable Wolters Kluwer to sharpen its focus on U.S. banking compliance and corporate legal services. The...

Commercial Launch of Ryoncil Yields Strong First-Quarter Revenue

The commercial launch of Ryoncil has delivered encouraging results for Mesoblast, with $13.2 million in gross revenue recorded in the first quarter following market entry (March 28 to June 30, 2025). Early Commercial Uptake and Market Penetration Since its debut, Ryoncil has been successfully integrated into...

THC Therapeutics Acquisition of SugarTop Buddery Reinforces Strategic National Expansion

THC Therapeutics Acquisition of SugarTop Buddery has been confirmed in an all-share transaction valued at approximately $3 million, entirely settled through newly issued Series D Preferred stock. This strategic acquisition further strengthens THC Therapeutics, Inc. (OTC: THCT) as it builds a bi-coastal, vertically integrated...